Funding Received
$40.7 Million in 7 Rounds from 9 Investors
Most Recent Funding
$269 Thousand on April 6, 2012 / Undisclosed Round
Headquarters:
New Haven, CT
Description:
BioRelix is engaged in the discovery and development of anti-biotic drug candidates for the treatment of infectious diseases.
Categories:
Biotechnology
Website:
http://www.biorelix.com

Company Details

Update

BioRelix, Inc., a biopharmaceutical company, engages in the discovery and development of anti-biotic drug candidates for the treatment of infectious diseases in the United States. It develops a portfolio of riboswitch-based therapeutic agents to overcome the lethal and devastating causes of bacterial infections. The company was founded in 2005 and is based in New Haven, Connecticut.

Funding Rounds (7) - $269k

Update

Board Members and Advisors (7)

Update

Investors (9)

Update

Offices/Locations (1)

Update
  • Office

    5 Science Park

    401 Winchester Avenue

    New Haven, CT 06511

    USA